0001193125-22-062963.txt : 20220302 0001193125-22-062963.hdr.sgml : 20220302 20220302160703 ACCESSION NUMBER: 0001193125-22-062963 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20220301 ITEM INFORMATION: Entry into a Material Definitive Agreement FILED AS OF DATE: 20220302 DATE AS OF CHANGE: 20220302 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Nurix Therapeutics, Inc. CENTRAL INDEX KEY: 0001549595 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 270838048 STATE OF INCORPORATION: DE FISCAL YEAR END: 1130 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39398 FILM NUMBER: 22703456 BUSINESS ADDRESS: STREET 1: 1700 OWENS STREET, SUITE 205 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: (415) 660-5320 MAIL ADDRESS: STREET 1: 1700 OWENS STREET, SUITE 205 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 FORMER COMPANY: FORMER CONFORMED NAME: Nurix, Inc. DATE OF NAME CHANGE: 20120509 8-K 1 d279430d8k.htm 8-K 8-K
false 0001549595 0001549595 2022-03-01 2022-03-01

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): March 1, 2022

 

 

NURIX THERAPEUTICS, INC.

(Exact Name of Registrant as Specified in its Charter)

 

 

 

Delaware   001-39398   27-0838048

(State or Other Jurisdiction of

Incorporation or Organization)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

1700 Owens Street, Suite 205

San Francisco, California

  94158
(Address of Principal Executive Offices)   (Zip Code)

(415) 660-5320

(Registrant’s Telephone Number, Including Area Code)

N/A

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

symbol(s)

 

Name of each exchange

on which registered

Common Stock, $0.001 par value per share   NRIX   Nasdaq Global Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 


Item 1.01

Entry into a Material Definitive Agreement.

On March 1, 2022, Nurix Therapeutics, Inc. (the “Company”) entered into a lease agreement (the “Lease”) with 8800 Technology Forest Pl, LLC, effective as of March 1, 2022, for the lease of approximately 46,434 square feet of office space located at 8800 Technology Forest Place, The Woodlands, Texas, for a research and development laboratory and related uses. The commencement date of the Lease is expected to be on or about August 1, 2022, and the Lease will expire on March 1, 2035, unless terminated earlier (the “Term”). The minimum rent payable by the Company under the Lease will be approximately $205,084 per month, beginning on August 1, 2022, which amount will increase by 3% per year over the Term; provided that, for the period between March 1, 2023 and February 29, 2024, the minimum rent payable by the Company under the lease will be approximately $153,813 per month. The Company will also be responsible for the payment of additional rent to cover the Company’s share of the annual operating and tax expenses and utilities costs for the building.

The foregoing description of the Lease does not purport to be complete and is qualified in its entirety by reference to the full text of the Lease, a copy of which will be filed as an exhibit to the Company’s Quarterly Report on Form 10-Q for the quarter ending May 31, 2022.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    NURIX THERAPEUTICS, INC.
Date: March 2, 2022     By:  

/s/ Arthur T. Sands

      Arthur T. Sands, M.D., Ph.D.
      President and Chief Executive Officer
EX-101.SCH 2 nrix-20220301.xsd XBRL TAXONOMY EXTENSION SCHEMA 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.LAB 3 nrix-20220301_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Cover [Abstract] Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Document Type Document Type Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Incorporation State Country Code Entity Incorporation State Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre Commencement Tender Offer Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Security 12b Title Security 12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company EX-101.PRE 4 nrix-20220301_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 5 R1.htm IDEA: XBRL DOCUMENT v3.22.0.1
Document and Entity Information
Mar. 01, 2022
Cover [Abstract]  
Amendment Flag false
Entity Central Index Key 0001549595
Document Type 8-K
Document Period End Date Mar. 01, 2022
Entity Registrant Name NURIX THERAPEUTICS, INC.
Entity Incorporation State Country Code DE
Entity File Number 001-39398
Entity Tax Identification Number 27-0838048
Entity Address, Address Line One 1700 Owens Street
Entity Address, Address Line Two Suite 205
Entity Address, City or Town San Francisco
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94158
City Area Code (415)
Local Phone Number 660-5320
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Common Stock, $0.001 par value per share
Trading Symbol NRIX
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
XML 6 d279430d8k_htm.xml IDEA: XBRL DOCUMENT 0001549595 2022-03-01 2022-03-01 false 0001549595 8-K 2022-03-01 NURIX THERAPEUTICS, INC. DE 001-39398 27-0838048 1700 Owens Street Suite 205 San Francisco CA 94158 (415) 660-5320 false false false false Common Stock, $0.001 par value per share NRIX NASDAQ false EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.0.1 html 1 118 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.nurixtx.com//20220301/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports d279430d8k.htm nrix-20220301.xsd nrix-20220301_lab.xml nrix-20220301_pre.xml http://xbrl.sec.gov/dei/2021 true false JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d279430d8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "d279430d8k.htm" ] }, "labelLink": { "local": [ "nrix-20220301_lab.xml" ] }, "presentationLink": { "local": [ "nrix-20220301_pre.xml" ] }, "schema": { "local": [ "nrix-20220301.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd", "https://xbrl.sec.gov/naics/2021/naics-2021.xsd" ] } }, "elementCount": 24, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 118, "memberCustom": 0, "memberStandard": 0, "nsprefix": "nrix", "nsuri": "http://www.nurixtx.com/20220301", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "d279430d8k.htm", "contextRef": "duration_2022-03-01_to_2022-03-01", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "role": "http://www.nurixtx.com//20220301/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "d279430d8k.htm", "contextRef": "duration_2022-03-01_to_2022-03-01", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.nurixtx.com//20220301/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.nurixtx.com//20220301/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.nurixtx.com//20220301/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.nurixtx.com//20220301/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.nurixtx.com//20220301/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.nurixtx.com//20220301/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.nurixtx.com//20220301/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.nurixtx.com//20220301/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.nurixtx.com//20220301/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.nurixtx.com//20220301/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.nurixtx.com//20220301/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.nurixtx.com//20220301/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.nurixtx.com//20220301/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.nurixtx.com//20220301/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.nurixtx.com//20220301/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.nurixtx.com//20220301/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.nurixtx.com//20220301/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre Commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.nurixtx.com//20220301/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security 12b Title", "terseLabel": "Security 12b Title" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.nurixtx.com//20220301/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.nurixtx.com//20220301/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.nurixtx.com//20220301/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.nurixtx.com//20220301/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.nurixtx.com//20220301/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 13 0001193125-22-062963-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-22-062963-xbrl.zip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end